31 results on '"Dussart C"'
Search Results
2. HTA74 Could Artificial Intelligence Support Prediction of Reimbursement Decisions in Scotland? A Pilot Project
3. POSB263 Analysis of the Influence of Implicit Factors on the HTA Deliberative Process: Results of a Survey in 5 European Countries
4. PMU9 HIGH DRUG PRICES AND THE ADEQUACY OF RETURN ON PUBLIC INVESTMENT INTO DRUG RESEARCH AND DEVELOPMENT BY THE U.S. NATIONAL INSTITUTES OF HEALTH (NIH).
5. PND108 QUALITY OF LIFE OF PATIENTS AFTER ISCHAEMIC STROKE TREATED IN A PROVINCIAL HOSPITAL IN POLAND
6. PMH8 PSYCHOLOGICAL ASPECTS OF GENETIC COUNSELING IN RARE GENETIC CNS DISORDERS - SHOULD REGULATORS BE MORE INVOLVED?
7. PHP125 - COHORT TEMPORARY AUTHORISATION FOR USE IN FRANCE, FRENCH EXPERIENCE OF EARLY-ENTRY PROGRAM 2014-2018
8. PHP118 - IMPACT OF COHORT TEMPORARY AUTHORISATION FOR USE ON PRICE IN FRANCE
9. PCP33 - COULD THE US ADMINISTRATION IMPOSE DRUG PRICE RAISES IN THE EUROPEAN UNION (EU)?
10. PSY45 - BUDGET IMPACT ANALYSIS OF THE PATIENT BLOOD MANAGEMENT FROM A FRENCH NATIONAL PAYER AND HOSPITAL PERSPECTIVES IN FRANCE
11. PSY159 - COMPARISON OF ORPHAN DRUG PRICES: BELGIUM VS LUXEMBOURG
12. PHP345 - INNOVATIVE PAYMENT MODELS FOR BREAKTHROUGH THERAPIES
13. PSY150 - INEQUITY OF ORPHAN DRUGS PRICES IN EUROPE
14. Orphan Drugs Versus Ultra-Orphan Drugs: Price Comparison in England
15. Patient-Reported Outcome Claims in European and United States Orphan Drug Approvals
16. Assessment of Hta and Price Heterogeneity of Oncology Products: A Comparison Between France and Germany
17. Rates of Patient-Reported Outcome Claims for Orphan Drugs Approved by the European Medicines Agency
18. Hta Outcomes for Orphan Drugs in Oncology: Comparison of France, Germany and England
19. Non-Profit Drug Research and Development at a Crossroads: The Case Study of Genethon
20. Does Disease Area Have An Impact on Orphan Drug Prices?
21. Potential Funding Sources For Breakthrough Therapies
22. Could Healthcoin Be A Revolution In Healthcare?
23. PSY32 - Hta Outcomes for Orphan Drugs in Oncology: Comparison of France, Germany and England
24. PSY22 - Patient-Reported Outcome Claims in European and United States Orphan Drug Approvals
25. PSY21 - Rates of Patient-Reported Outcome Claims for Orphan Drugs Approved by the European Medicines Agency
26. PSY6 - Orphan Drugs Versus Ultra-Orphan Drugs: Price Comparison in England
27. PMU18 - Does Disease Area Have An Impact on Orphan Drug Prices?
28. PCP9 - Non-Profit Drug Research and Development at a Crossroads: The Case Study of Genethon
29. PCN102 - Assessment of Hta and Price Heterogeneity of Oncology Products: A Comparison Between France and Germany
30. PHP115 - Could Healthcoin Be A Revolution In Healthcare?
31. PHP44 - Potential Funding Sources For Breakthrough Therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.